07:02 AM EDT, 09/23/2026 (MT Newswires) -- Omda (OMDA.OL) completed the rollout of its oncology medication software, Omda Cytodose, across Norway's largest health region in early September. The rollout across the South-Eastern Norway Regional Health Authority further bolsters Omda Cytodose's position as the market-leading oncology medication management software in Norway and Sweden, according to a Wednesday release. The Norwegian health software company added that Omda Cytodose is expanding in Finland after its first client went live in March 2025.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.